Abstract:Adenosine is a purine nucleoside that, via activation of distinct G protein-coupled receptors, modulates inflammation and immune responses. Under pathological conditions and in response to inflammatory stimuli, extracellular ATP is released from damaged cells and is metabolized to extracellular adenosine. However, studies over the past 30 years provide strong evidence for another source of extracellular adenosine, namely the "cAMP-adenosine pathway." The cAMP-adenosine pathway is a biochemical mechanism mediated by ATP-binding cassette transporters that facilitate cAMP efflux and by specific ectoenzymes that convert cAMP to AMP (ecto-PDEs) and AMP to adenosine (ecto-nucleotidases such as CD73). Importantly, the cAMP-adenosine pathway is operative in many cell types, including those of the airways. In airways, β2-adrenoceptor agonists, which are used as bronchodilators for treatment of asthma and chronic respiratory diseases, stimulate cAMP efflux and thus trigger the extracellular cAMP-adenosine pathway leading to increased concentrations of extracellular adenosine in airways. In the airways, extracellular adenosine exerts pro-inflammatory effects and induces bronchoconstriction in patients with asthma and chronic obstructive pulmonary diseases. These considerations lead to the hypothesis that the cAMP-adenosine pathway attenuates the efficacy of β2-adrenoceptor agonists. Indeed, our recent findings support this view. In this mini-review, we will highlight the potential role of the extracellular cAMP-adenosine pathway in chronic respiratory inflammatory disorders, and we will explore how extracellular cAMP could interfere with the regulatory effects of intracellular cAMP on airway smooth muscle and innate immune cell function. Finally, we will discuss therapeutic possibilities targeting the extracellular cAMP-adenosine pathway for treatment of these respiratory diseases.

Calcium Signaling in Airway Epithelial Cells: Current Understanding and Implications for Inflammatory Airway Disease

The calcium-sensing receptor in inflammation: Recent updates

Regulation of Airway Epithelial-Derived Alarmins in Asthma: Perspectives for Therapeutic Targets

Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update

Notch Signaling: Linking Embryonic Lung Development and Asthmatic Airway Remodeling

Epithelial-neuronal-immune cell interactions: implications for immunity, inflammation, and tissue homeostasis at mucosal sites

Novel regulators of airway epithelial barrier function during inflammation: potential targets for drug repurposing

Airway Epithelium Controls Lung Inflammation and Injury Through the NF-kappa B Pathway.

Cytokine targets in airway inflammation

Mechanosensitive membrane domains regulate calcium entry in arterial endothelial cells to protect against inflammation

Extracellular cAMP-Adenosine Pathway Signaling: A Potential Therapeutic Target in Chronic Inflammatory Airway Diseases

Airway remodelling in asthma and the epithelium: on the edge of a new era

Calcium-Sensing Receptor (CaSR), Its Impact on Inflammation and the Consequences on Cardiovascular Health

Adenosine A(1) and Prostaglandin E Receptor 3 Receptors Mediate Global Airway Contraction after Local Epithelial Injury.

Airway Epithelial Dysfunction in the Development of Acute Lung Injury and Acute Respiratory Distress Syndrome.

Inflammatory gene regulation by Cdc42 in airway epithelial cells

Role of Airway Epithelial Cells in Development of Chronic Obstructive Pulmonary Disease

The Physiopathologic Roles of Calcium Signaling in Podocytes

Faculty Opinions Recommendation of Extracellular Calcium-Sensing Receptor Mediates Human Bronchial Epithelial Wound Repair.

Epithelial alarmins: a new target to treat chronic respiratory diseases

Role of Airway Epithelial Cells in Development of Asthma and Allergic Rhinitis